However, further longitudinal studies are needed to determine the concentrations of MIP-1α and MIP-1β in periodontal disease tissues and GCF, to clarify their role in the periodontitis pathogenesis, and to validate MIP-1α and MIP-1β as novel biomarkers for periodontal disease progression. This evidence concerns the gene CCL3 and periodontal disorder.